Kilic Y, Kamal S, Jaffar F, Sriranganathan D, Quraishi MN, Segal JP. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. Published online April 12, 2023:izad061. https://doi.org/10.1093/ibd/izad061.

Gajendran M, Loganathan P, Jimenez G et al. A comprehensive review and update on ulcerative colitis. Dis-Mon DM. 2019;65:100851. https://doi.org/10.1016/j.disamonth.2019.02.004.

Article  PubMed  Google Scholar 

Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn’s disease. Dis-Mon DM. 2018;64:20–57. https://doi.org/10.1016/j.disamonth.2017.07.001.

Article  PubMed  Google Scholar 

Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020;35:380–389. https://doi.org/10.1111/jgh.14872.

Article  PubMed  Google Scholar 

Alsakarneh S, Ahmed M, Jaber F et al. Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990–2019. Ann Gastroenterol. 2024;37:527–535. https://doi.org/10.20524/aog.2024.0909.

Article  PubMed  PubMed Central  Google Scholar 

Alsakarneh S, Hassan K, Jaber F et al. The national burden of inflammatory bowel disease in the United States from 1990–2019: results from the Global Burden of Disease study database. Ann Gastroenterol. 2024;37:427–435. https://doi.org/10.20524/aog.2024.0894.

Article  PubMed  PubMed Central  Google Scholar 

Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet Lond Engl. 2017;390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0.

Article  Google Scholar 

Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–217. https://doi.org/10.1038/nrgastro.2015.34.

Article  PubMed  Google Scholar 

Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22:4794–4801. https://doi.org/10.3748/wjg.v22.i20.4794.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faye AS, Holmer AK, Axelrad JE. Cancer in Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2022;51:649–666. https://doi.org/10.1016/j.gtc.2022.05.003.

Article  PubMed  Google Scholar 

Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441–1452. https://doi.org/10.1056/NEJMra1403718.

Article  CAS  PubMed  Google Scholar 

Axelrad JE, Hashash JG, Itzkowitz SH. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2024;22:1365–1372. https://doi.org/10.1016/j.cgh.2024.03.032.

Article  Google Scholar 

Shah SC, Itzkowitz SH. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology. 2022;162:715-730.e3. https://doi.org/10.1053/j.gastro.2021.10.035.

Article  PubMed  Google Scholar 

Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535. https://doi.org/10.1136/gut.48.4.526.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Slesser AAP, Bhangu A, Bower M, Goldin R, Tekkis PP. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol. 2013;22:230–237. https://doi.org/10.1016/j.suronc.2013.08.002.

Article  CAS  PubMed  Google Scholar 

Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TIA. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–2729. https://doi.org/10.1111/j.1572-0241.2005.00287.x.

Article  PubMed  Google Scholar 

Sokol H, Beaugerie L, Maynadié M et al. Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2063–2071. https://doi.org/10.1002/ibd.22889.

Article  PubMed  Google Scholar 

Neurath MF. Current ad emerging therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol. 2017;14:269–278. https://doi.org/10.1038/nrgastro.2016.208.

Article  CAS  PubMed  Google Scholar 

Beaugerie L, Brousse N, Bouvier AM et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet Lond Engl. 2009;374:1617–1625. https://doi.org/10.1016/S0140-6736(09)61302-7.

Article  CAS  Google Scholar 

Lopez A, Mounier M, Bouvier AM et al. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12:1324–1329. https://doi.org/10.1016/j.cgh.2014.02.026.

Article  CAS  Google Scholar 

Singh S, Nagpal SJS, Murad MH et al. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12:210–218. https://doi.org/10.1016/j.cgh.2013.04.033.

Article  Google Scholar 

Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2010;8:268–274. https://doi.org/10.1016/j.cgh.2009.11.024.

Article  Google Scholar 

Bourrier A, Carrat F, Colombel JF et al. Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Aliment Pharmacol Ther. 2016;43:252–261. https://doi.org/10.1111/apt.13466.

Article  CAS  PubMed  Google Scholar 

Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193–199. https://doi.org/10.7150/ijms.3635.

Article  PubMed  PubMed Central  Google Scholar 

Kamran SC, D’Amico AV. Radiation Therapy for Prostate Cancer. Hematol Oncol Clin North Am. 2020;34:45–69. https://doi.org/10.1016/j.hoc.2019.08.017.

Article  PubMed  Google Scholar 

Czito BG, Meyer J. Radiation therapy in anal and rectal cancer. Surg Oncol Clin N Am. 2013;22:525–543. https://doi.org/10.1016/j.soc.2013.02.010.

Article  PubMed  Google Scholar 

Chen W, Chiang CL, Dawson LA. Efficacy and safety of radiotherapy for primary liver cancer. Chin Clin Oncol. 2021;10:9. https://doi.org/10.21037/cco-20-89.

Article  PubMed  Google Scholar 

Badiyan SN, Molitoris JK, Chuong MD, Regine WF, Kaiser A. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings. Surg Oncol Clin N Am. 2017;26:431–453. https://doi.org/10.1016/j.soc.2017.01.012.

Article  PubMed  Google Scholar 

Bodofsky S, Freeman RH, Hong SS et al. Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review. J Gastrointest Oncol. 2022;13:2565–2582. https://doi.org/10.21037/jgo-22-138.

Article  PubMed  PubMed Central  Google Scholar 

Cherian S, Kittel JA, Reddy CA et al. Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis. Pract Radiat Oncol. 2015;5:e437–e442. https://doi.org/10.1016/j.prro.2015.03.002.

Article  PubMed  Google Scholar 

Chang BW, Kumar AMS, Koyfman SA, Kalady M, Lavery I, Abdel-Wahab M. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits. Int J Colorectal Dis. 2015;30:403–408. https://doi.org/10.1007/s00384-014-2103-8.

Article  PubMed  Google Scholar 

White EC, Murphy JD, Chang DT, Koong AC. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy. Am J Clin Oncol. 2015;38:564–569.